Skip to content

Role of seed cycling and physiotherapy in PCOD.

Role of an integrated seed cycling and physiotherapy in reproductive hormones and quality of life among young PCOD females- A randomized controlled trial. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112717
Enrollment
159
Registered
2026-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Intervention Group composed of seed cycling and physiotherapy: Participants in Group 1 will receive Seed Cycling along with a structured Physiotherapy Program for a duration of 6 weeks.
7 gm) and pumpkin seeds (1 tablespoon/day
9 gm). During the luteal phase (Week 4 6), participants will consume sesame seeds (1 tablespoon/day
9 gm) and sunflower seeds (1 tablespoon/day
10 gm). All seeds will be freshly ground and consumed with meals. The physiotherapy protocol will be divided into three phases. Phase 1 (Week 1 2) will include warm-up exercises for 5 minutes, core st

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed with PCOD based on Rotterdam criteria History of irregular menstrual cycles for at least the last 6 months Body Mass Index between 18.5-29.9 kg/m as per Indian standards Not engaged in any structured exercise program in the last 3 months Willing to follow seed cycling dietary protocol Not taking any seed cycle for the past 3 months Ability to understand and follow verbal instructions and can understand English Willingness to provide written informed consent

Exclusion criteria

Exclusion criteria: Pregnancy or lactation Use of hormonal therapy or oral contraceptive pills in the last 3 months Known endocrine disorders other than PCOD thyroid disorders Cushings syndrome Diagnosed cardiovascular neurological or severe musculoskeletal conditions Uncontrolled diabetes mellitus or hypertension History of ovarian surgery Known allergy to flax pumpkin sesame or sunflower seeds Participation in another interventional study Psychiatric illness affecting compliance Severe obesity

Design outcomes

Primary

MeasureTime frame
The outcome measures assessed at baseline and after 6 weeks of intervention will include the Working ability, Location, Intensity, Days of pain, and Dysmenorrhea(WALLID) Scale, reproductive hormonal profile including Luteinizing Hormone (LH), Follicle Stimulating Hormone (FSH), and Testosterone levels, LH/FSH ratio, Body Mass Index (BMI), and Waist Circumference.Timepoint: Total study duration is 6 weeks The data will be collected at baseline and after 6 weeks.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactJYOTI SHARMA

Galgotias university

jyoti.sharma@galgotiasuniversity.edu.in9717161626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026